Navigation Links
Visionary concept earns La Jolla Institute scientist prestigious NIH Pioneer Award
Date:9/24/2009

SAN DIEGO (September 24, 2009) A scientist at the La Jolla Institute for Allergy & Immunology has received one of the National Institutes of Health (NIH)'s top awards -- the 2009 NIH Director's Pioneer Award. The prestigious prize carries with it funding for total costs of up to $4.7 million over five years, and is designed to support the work of exceptionally creative scientists, whose novel proposals offer the potential to make extraordinary contributions to human health.

Hilde Cheroutre, Ph.D., received the award during the Pioneer Award Symposium today at the NIH headquarters in Bethesda, Maryland. NIH Director Francis S. Collins, M.D., Ph.D., announced the winners. Dr. Cheroutre is one of a select group of 18 scientists nationwide chosen for the 2009 prize from among more than 2,300 applicants. The award will fund her innovative research proposal that, if successful, would create a new way of detecting, treating and possibly preventing autoimmune diseases, with the potential for identifying high risk for autoimmunity in newborns.

In announcing the winners, the NIH said the awards are part of its ongoing efforts to encourage highly creative scientists to explore bold ideas that have the potential to catapult fields forward and speed the translation of research into improved health.

"Leaps in knowledge often result from exceptional minds exploring ideas that were considered risky at their inception, especially in the absence of strong supportive data," said an NIH statement describing the awards. "The changing face of biomedical research calls for support of aggressive risk-taking and innovation that will produce tomorrow's conceptual and technological breakthroughs."

Nilabh Shastri, Ph.D., a prominent scientist and immunology professor at UC Berkeley, who previously worked with Dr. Cheroutre, said her selection "justifies the existence of such awards."

"Dr. Cheroutre possesses a remarkable and rare c
'/>"/>

Contact: Bonnie Ward
contact@liai.org
619-303-3160
La Jolla Institute for Allergy and Immunology
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. NYU biologist Bonneau named among 20 "visionary" scientists under 40 by Discover magazine
2. Heat stress influences low conception of dairy herds
3. Misconceptions about Alzheimers varies among races, survey suggests
4. New Delft material concept for aircraft wings could save billions
5. Resilience concepts poised to aid management of coastal marine ecosystems
6. Moms obesity during conception phase may set the stage for offsprings obesity risk
7. Aquaculture concept leaves judges goggle eyed
8. Children born after donor insemination should be told as soon as possible about their conception
9. New roadside beautification concept studied
10. PTC124 shows activity in cystic fibrosis; Phase 2 proof-of-concept data published in Lancet
11. M&Ms as diet food? 100-calorie pack misconceptions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2014)... N.C. , Dec. 9, 2014  Wake Forest Baptist ... education building for its School of Medicine. Funding for ... larger capital campaign that will be publicly launched next ... be located in the former 60 series R.J. Reynolds ... Innovation Quarter. Construction will begin immediately with plans to ...
(Date:12/5/2014)... MOUNTAIN VIEW, Calif. , Dec. 4, 2014 ... and safety has boosted investments in new testing ... products has also given rise to a range ... driven by the requirements of Generation Y, which ... digital technologies. As a result, product development strategies ...
(Date:12/3/2014)... , Dec. 2, 2014 As part ... readers, Inception Technologies is pleased to announce the release ... for customers to collect the workforce data that they ... that have been left by existing readers. Many such ... interface, connectivity and modern technology. Older models force users ...
Breaking Biology News(10 mins):Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4Inception Technologies to Release New Biometric Reader 2
... scientific institutions today announced the launch of the Encyclopedia ... 1.8 million named species of animals, plants, and other ... time in the history of the planet, scientists, students, ... living species, even those that have just been discovered. ...
... that could revolutionize manufacturing for certain materials, researchers have ... world. While still slightly less than 2 centimeters long, ... , The fibers--which have the potential to be longer, ... many other materials--could ultimately find use in smart fabrics, ...
... study examines the use of tissue-engineered scaffolding made of ... naturally, to replace defective cartilage tissue. Cartilage cells are ... into the body, where new cartilage tissue is grown ... Artificial Organs. , The procedure was extremely successful in ...
Cached Biology News:World's leading scientists announce creation of 'Encyclopedia of Life' 2World's leading scientists announce creation of 'Encyclopedia of Life' 3World's leading scientists announce creation of 'Encyclopedia of Life' 4The longest carbon nanotubes you've ever seen 2
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
(Date:12/17/2014)... SOUTH SAN FRANCISCO, Calif. , Dec. 17, ... positive results of a Phase 2 study evaluating ... for the treatment of patients with severe, chronic ... the current standard of care, including topical steroids ... endpoint was percent change in Visual Analog Scale ...
(Date:12/15/2014)...  GlassesOff Inc. (OTCBB: GLSO) announced today the appointment ... director of the Company,s Board of Directors. ... its CEO until its acquisition by Stanley Black ... Recognized as the inventor of the first Wi-Fi-based Active ... -based RFID solutions focused on improving operational efficiency, safety ...
(Date:12/13/2014)... (PRWEB) December 12, 2014 Clarassance, a ... announced its new name: Therabron Therapeutics , Inc. ... and bronchioles (a type of structure in the lungs ... company’s mission to develop novel protein therapeutics for the ... directors decided to change the name to mark the ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
... IDIX ) announced today that it will report,its ... Tuesday, November 6,2007 after the U.S. financial markets close. ... release, Idenix,management will host a conference call at 4:30 ... company,s financial results for the third quarter,2007. To ...
... 31 Modigene Inc. (OTC,Bulletin Board: MODG) today announced ... & Renshaw 9th Annual Healthcare Conference on,Wednesday, November 7, ... held at,the New York Palace Hotel in New York ... Novik will attend.,Management will provide a company overview and ...
... DIEGO, Oct. 31 Anadys Pharmaceuticals,Inc. (Nasdaq: ANDS ... Acumen,BioFin(TM) Rodman & Renshaw 9th Annual Healthcare Conference on ... PST). The conference is being,held at the New York ... Executive Officer of Anadys,Pharmaceuticals, Inc. will present an overview ...
Cached Biology Technology:Modigene to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 2Anadys Pharmaceuticals to Present at the Acumen BioFin Rodman & Renshaw Healthcare Conference 2
... cassette is designed to allow ampicillin selection ... gb2 driving the gene for ampicillin resistance ... Em7 promoter. It mediates higher transcription efficiency ... synthetic polyadenylation signal terminates the ampicillin expression. ...
... cassette is designed to allow ampicillin ... promoter gb2 driving the gene for ampicillin ... the Em7 promoter. It mediates higher transcription ... A synthetic polyadenylation signal terminates the ampicillin ...
... is designed for the fast and simple ... at any position (for the generation of ... is designed to allow neomycin / kanamycin ... combines a prokaryotic promoter (gb2) for expression ...
... Pyronin Y is most widely used ... selectively and differentially stain nucleic acids ... dichromatic dye solution, Pyronin Y stains ... DNA green. Chem comp: ...
Biology Products: